Lederman Seth's Form 4 filing
Tonix Pharmaceuticals Holding Corp. (TNXP) · filed Aug 31, 2026
- Accession no.
- 0001493152-26-040736
- Filed
- Aug 31, 2026, 8:00 AM ET
- Trade date
- Aug 27, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $27.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lederman SethCIK 0001563420 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Common Stock, $0.001 par value | PPurchaseAcquired | +2,000 | $13.79 | +$27,580 | 11,005 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.